Koers Alexion Pharmaceuticals, Inc.
Aandelen
ALXN
US0153511094
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 71 | - |
Sean Christie
DFI | Director of Finance/CFO | - | 01-08-21 |
Chief Tech/Sci/R&D Officer | - | 01-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+27,97% | 672 mld. | |
+23,84% | 550 mld. | |
-7,02% | 351 mld. | |
+14,85% | 317 mld. | |
+6,25% | 292 mld. | |
+2,43% | 211 mld. | |
-0,92% | 203 mld. | |
-10,51% | 194 mld. | |
-11,81% | 144 mld. |